Which of the following is the new drug for the treatment of multi drug resistant tuberculosis: (A) Bedaquline, (B) Linezolide, (C) Levofloxacin, (D) Cefepime
Answer is A. Refer Harrison 19th/p1115 Bedaquline is a new drug approved for MDT tuberculosis. It acts by inhibiting ATP synthatase in mycobacterium . Major adverse effects of this drug is "QT prolongation